Airbus taps Lars Wagner as CEO of its commercial aircraft business from 2026-February 2024-www.financetom.com

Airbus taps Lars Wagner as CEO of its commercial aircraft business from 2026

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Airbus taps Lars Wagner as CEO of its commercial aircraft business from 2026

Jul 10, 2025 4:51 AM

(Reuters) -Airbus said on Thursday that Lars Wagner would become the CEO of its commercial aircraft business from January 1, 2026.

The current CEO of MTU Aero Engines will join the French planemaker from the start of November 2025 to ensure a smooth transition as he takes over from Christian Scherer, the company said.

(Reporting by Mathias de Rozario in Gdansk)

Previous page： Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy Next page： Cassava Sciences Simufilam Misses Endpoints in Late-Stage Alzheimer's Trial; Shares Drop Pre-Bell

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy

Nov 25, 2024

08:11 AM EST, 11/25/2024 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) said Monday the US Food and Drug Administration has accepted its supplemental new drug application for vutrisiran, an investigational RNAi therapeutic for the treatment of ATTR amyloidosis with cardiomyopathy. The FDA has set a target action date of March 23 and is not planning to hold an advisory...

Cassava Sciences Simufilam Misses Endpoints in Late-Stage Alzheimer's Trial; Shares Drop Pre-Bell

Nov 25, 2024

08:13 AM EST, 11/25/2024 (MT Newswires) -- Cassava Sciences ( SAVA ) said Monday that its late-stage trial of simufilam in mild-to-moderate Alzheimer's disease did not meet the co-primary endpoints of cognitive and functional improvement. Secondary and exploratory biomarker endpoints also were not met, the clinical-stage company said, adding that the drug maintained a favorable safety profile despite the trial...

Citigroup awards special retention bonuses for hundreds, Bloomberg News reports

Nov 25, 2024

(Reuters) - Citigroup ( C/PN ) has greenlit special retention bonuses for hundreds of personnel this year as the Wall Street giant looks to prevent more bankers from leaving, Bloomberg News reported on Monday. (Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Arun Koyyur) ...

Top Premarket Decliners

Nov 25, 2024

08:10 AM EST, 11/25/2024 (MT Newswires) -- Oncternal Therapeutics ( ONCT ) shares tumbled 33% in recent Monday premarket activity after it said in a regulatory filing that Nasdaq believes the company is a public shell and will adopt more stringent criteria for its listing after its Nov. 14 announcement of workforce reduction. Actuate Therapeutics ( ACTU ) stock fell...